Fatih Karakaya
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Histological disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy.
Journal: European journal of gastroenterology & hepatology
Published: May 06, 2024
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
Journal: European radiology
Published: September 04, 2023
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
Journal: Hepatology forum
Published: December 12, 2020
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Journal: Hepatology (Baltimore, Md.)
Published: October 06, 2020
Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 09, 2019
Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
Journal: European journal of gastroenterology & hepatology
Published: January 24, 2019
Percutaneous treatment with the Örmeci technique for hydatid disease located in the spleen: Single center experience for twenty six years.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: September 28, 2018
Rare But Life-Threatening Complication of Hydatid Disease.
Journal: Turkiye parazitolojii dergisi
Published: October 17, 2017
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort.
Journal: Hepatology (Baltimore, Md.)
Published: September 25, 2017
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study.
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study.
Journal: Hepatology (Baltimore, Md.)
Published: September 18, 2017
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease.
Journal: The Journal of infectious diseases
Published: August 26, 2017
Last Updated: 09/26/2026